|
|
||||||||
Clinical Investigations |
Department of Physics and Nuclear Medicine, City Hospital NHS Trust, Birmingham, United Kingdom
| ABSTRACT |
|---|
|
|
|---|
Key Words: sentinel lymph node breast tumor lymph node imaging
| INTRODUCTION |
|---|
|
|
|---|
-probe is used in the theater to localize the node. Blue dye may also be injected at the time of surgery for visual identification of the nodes. The identified nodes undergo biopsy and are examined microscopically for the presence of tumor cells. Nuclear medicine gamma camera imaging before breast surgery has a high rate of SLN detection; however, its real value is to provide accurate localization of nodes within the body to aid the surgeon. Such accuracy requires a body-outline view that clearly identifies the location of the nodes. The aim of this study was to provide a technique that can achieve this body-outline view on both anterior and lateral projections. In addition to aiding quick identification by probe during surgery, the gamma camera images may identify SLNs at unsuspected areas such as internal mammary nodes and may thus have a profound effect on the surgical approach. | MATERIALS AND METHODS |
|---|
|
|
|---|
Three methods of determining body outline were used in this study. Manual body outline was used initially on 24 patients. Images were acquired on a single-head Basicam camera (Siemens Medical Systems, Inc., Hoffman Estates, IL) fitted with a general-purpose collimator. Two 300-s acquisitions were performed in the anterior and oblique projections of the affected breast. After the anterior acquisition, a body-outline image was collected by holding a small source (2 MBq of 99mTc in point source) and manually moving it around the affected breast and edge of the body while acquiring the image (Fig. 1).
|
|
Because the counts around the injection sites in the tumor area in the emission view were high, the image was rescaled to optimize the image for SLN detection. This scaled image was then added to the transmission image to achieve the final display images for both anterior and lateral projections (Fig. 3).
|
| RESULTS |
|---|
|
|
|---|
A 57Co-flood source transmission outline (method 2) was adopted to enhance the image quality and SLN localization. Although the SLN was identified and the outline image quality was improved, surgeons were dissatisfied because only an anterior transmission view was possible.
With the use of a 153Gd-line source transmission outline (method 3), it was possible to obtain transmission images in all positions. Good-quality body-outline images were achieved for both anterior and lateral views with a superimposed SLN image for all patients.
In this group, 73% of SLNs were visualized by imaging, 96% by the probe and 68% by the blue dye. The surgeons asked for anterior and lateral views and found that localization of the SLN with these images was helpful for their approach and speed of localization. Their mean localization and SLN resection time was 14 min.
| DISCUSSION |
|---|
|
|
|---|
A 57Co body outline has been used for transmission for both SLN and lung studies in the past. Drawbacks include a high radiation dose to the patient and operator and limitation to a single view with a 57Co-source placed under the imaging bed. Most surgeons find oblique or lateral views more helpful than anterior views alone for lymph node identification.
A 153Gd-line source (or alternative point or line source) is available on most dual-head cameras for attenuation correction of tomographic images. The source produces body-outline transmission images that have helped us more clearly localize the SLN nodes before surgery than was previously possible. SLN and transmission images are acquired simultaneously, and images can be acquired in any angle desired. Our surgeons preferred lateral and anterior views; however, oblique views with a body outline can be acquired if requested.
A 153Gd-line source gives a clear, crisp body-outline image. This technique also gives a low radiation dose to the patient and none to the operator. The radiation dose to the patient for an SLN study is approximately 200400 µSv. The extra radiation dose to the patient from the 153Gd-source is 3 µSv per view (2), 1% of the total patient dose from the SLN study. The dose from the 57Co-flood source is 70 µSv (3), a 25% increase in total patient study dose. The line source transmission technique described is simple and quick and can be performed on most dual-head cameras with attenuation correction capability. The technique can also be used to acquire images from any aspect. Body-outline images were consistently of good quality regardless of the experience of the technologist.
| CONCLUSION |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
For correspondence or reprints contact: Elizabeth Clarke, HTEC, City Hospital NHS Trust, Dudley Rd., Birmingham B18 7QH, U.K.
E-mail: elizabeth.clarke{at}cityhospbham.wmids.nhs.uk
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. V. Mar, R. L. Dickinson, W. D. Erwin, and R. E. Wendt III Optimal 57Co Flood Source Activity and Acquisition Time for Lymphoscintigraphy Localization Images J. Nucl. Med. Technol., June 1, 2008; 36(2): 82 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Krynyckyi, S. Sata, I. Zolty, C. K. Kim, and K. Knesaurek Reducing Exposure from 57Co Sources During Breast Lymphoscintigraphy by Optimizing Energy Windows and Other Suggested Enhancements of Acquisition and the Display of Images J. Nucl. Med. Technol., December 1, 2004; 32(4): 198 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Krynyckyi, C. K. Kim, M. R. Goyenechea, P. T. Chan, Z.-Y. Zhang, and J. Machac Clinical Breast Lymphoscintigraphy: Optimal Techniques for Performing Studies, Image Atlas, and Analysis of Images RadioGraphics, January 1, 2004; 24(1): 121 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Krynyckyi, C. K. Kim, M. Goyenechea, J. Machac, and E. Clarke Methods to Outline the Patient During Lymphoscintigraphy J. Nucl. Med., June 1, 2003; 44(6): 992 - 993. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |